Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Methylphenidate, sold under the brand names Ritalin and Concerta, among others, is a central nervous system (CNS) stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It may be taken by mouth or applied to the skin, and different formulations have varying durations of effect. For ADHD, the effectiveness of…
History, Community, Culture & Applications
Explore the main themes, entities and connections around Methylphenidate. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
adhd dopamine effects may use treatment drug norepinephrine used amphetamine administration hours ritalin children doses reuptake adverse disorder studies increase
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Methylphenidate | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Methylphenidate | Addiction liability | Moderate | 1.00 | infobox |
| Methylphenidate | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Methylphenidate | ATC code | N06BA04 (WHO) | 1.00 | infobox |
| Methylphenidate | Bioavailability | Oral: ~30% (range: 11–52%) | 1.00 | infobox |
| Methylphenidate | Boiling point | 136 °C (277 °F) | 1.00 | infobox |
| Methylphenidate | CAS Number | 20748-11-2 Y | 1.00 | infobox |
| Methylphenidate | ChEBI | CHEBI:6887 Y | 1.00 | infobox |
| Methylphenidate | ChEMBL | ChEMBL796 Y | 1.00 | infobox |
| Methylphenidate | ChemSpider | 4015 Y | 1.00 | infobox |
| Methylphenidate | CompTox Dashboard (EPA) | DTXSID5023299 | 1.00 | infobox |
| Methylphenidate | Dependence liability | Physical: None Psychological: Moderate | 1.00 | infobox |
| Methylphenidate | Drug class | Stimulant; Norepinephrine–dopamine reuptake inhibitor (NDRI) | 1.00 | infobox |
| Methylphenidate | DrugBank | DB00422 Y | 1.00 | infobox |
| Methylphenidate | Duration of action | IR dosing: 3–4 hours | 1.00 | infobox |
| Methylphenidate | Duration of action | ER dosing: 8–12 hours | 1.00 | infobox |
| Methylphenidate | ECHA InfoCard | 100.003.662 | 1.00 | infobox |
| Methylphenidate | Elimination half-life | 2–3 hours | 1.00 | infobox |
| Methylphenidate | Excretion | Urine (90%) | 1.00 | infobox |
| Methylphenidate | Formula | C14H19NO2 | 1.00 | infobox |
| Methylphenidate | IUPHAR/BPS | 7236 | 1.00 | infobox |
| Methylphenidate | KEGG | D04999 Y | 1.00 | infobox |
| Methylphenidate | Legal status | AU: S8 (Controlled drug) | 1.00 | infobox |
| Methylphenidate | Legal status | BR: Class A3 (Psychoactive drugs) | 1.00 | infobox |
| Methylphenidate | Legal status | CA: Schedule III | 1.00 | infobox |
| Methylphenidate | Legal status | DE: Anlage III (Special prescription form required) | 1.00 | infobox |
| Methylphenidate | Legal status | NZ: Class B2 -authority required | 1.00 | infobox |
| Methylphenidate | Legal status | UK: Class B | 1.00 | infobox |
| Methylphenidate | Legal status | US: Schedule II | 1.00 | infobox |
| Methylphenidate | Legal status | UN: Psychotropic Schedule II | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.